QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
Qiagen NV (NYSE: QGEN) Delayed: 37.06 -0.36 (0.96%)
Previous Close $37.42    52 Week High $28.50 
Open $36.97    52 Week Low $19.94 
Day High $37.22    P/E 127.79 
Day Low $36.80    EPS $0.29 
Volume 1,894,689       

(NYSE: QIA) Delayed: 0.00 -10.35 (100%)
Previous Close $10.35    52 Week High $ 
Open $10.35    52 Week Low $ 
Day High $10.35    P/E N/A 
Day Low $10.35    EPS $ 
Volume 0